Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

522 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease.
Balci A, Sollie-Szarynska KM, van der Bijl AG, Ruys TP, Mulder BJ, Roos-Hesselink JW, van Dijk AP, Wajon EM, Vliegen HW, Drenthen W, Hillege HL, Aarnoudse JG, van Veldhuisen DJ, Pieper PG; ZAHARA-II investigators. Balci A, et al. Among authors: mulder bj. Heart. 2014 Sep;100(17):1373-81. doi: 10.1136/heartjnl-2014-305597. Epub 2014 Jul 17. Heart. 2014. PMID: 25034822
Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, Dunselman PH, Mulder BJ, Michels HR, Buser PT, van Gilst WH, Lie KI. van der Meer J, et al. Among authors: mulder bj. Thromb Haemost. 1994 Nov;72(5):676-81. Thromb Haemost. 1994. PMID: 7900073
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
van der Meer J, Brutel de la Rivière A, van Gilst WH, Hillege HL, Pfisterer M, Kootstra GJ, Dunselman PH, Mulder BJ, Lie KI. van der Meer J, et al. Among authors: mulder bj. J Am Coll Cardiol. 1994 Nov 1;24(5):1181-8. doi: 10.1016/0735-1097(94)90096-5. J Am Coll Cardiol. 1994. PMID: 7930237 Free article. Clinical Trial.
A comparison of internal mammary artery and saphenous vein grafts after coronary artery bypass surgery. No difference in 1-year occlusion rates and clinical outcome. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, van Gilst WH, Brutel de la Rivière A, Dunselman PH, Fidler V, Kootstra GJ, Mulder BJ, Pfisterer M, Lie KI. van der Meer J, et al. Among authors: mulder bj. Circulation. 1994 Nov;90(5):2367-74. doi: 10.1161/01.cir.90.5.2367. Circulation. 1994. PMID: 7955195 Clinical Trial.
Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
van der Meer J, Hillege HL, Kootstra GJ, Ascoop CA, Mulder BJ, Pfisterer M, van Gilst WH, Lie KI. van der Meer J, et al. Among authors: mulder bj. Lancet. 1993 Jul 31;342(8866):257-64. doi: 10.1016/0140-6736(93)91815-4. Lancet. 1993. PMID: 8101300 Clinical Trial.
522 results